These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 30108439)

  • 21. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
    Jang BG; Lee BL; Kim WH
    Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The prognostic role of Leucine-rich repeat-containing G-protein-coupled receptor 5 in gastric cancer: A systematic review with meta-analysis.
    Huang T; Qiu X; Xiao J; Wang Q; Wang Y; Zhang Y; Bai D
    Clin Res Hepatol Gastroenterol; 2016 Apr; 40(2):246-53. PubMed ID: 26387842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LGR5 expression and clinicopathological features of the invasive front in the fat infiltration area of pancreatic cancer.
    Kamakura M; Uehara T; Iwaya M; Asaka S; Kobayashi S; Nakajima T; Kinugawa Y; Nagaya T; Yoshizawa T; Shimizu A; Ota H; Umemura T
    Diagn Pathol; 2022 Feb; 17(1):21. PubMed ID: 35123536
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of leucine-rich repeat-containing G-protein (Lgr5) and its impact on clinicopathological features of colorectal cancer.
    Gzil A; Zarębska I; Jaworski D; Antosik P; Durślewicz J; Maciejewska J; Domanowska E; Skoczylas-Makowska N; Ahmadi N; Grzanka D; Szylberg Ł
    J Cancer Res Clin Oncol; 2020 Oct; 146(10):2547-2557. PubMed ID: 32671503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LGR5 is associated with tumor aggressiveness in papillary thyroid cancer.
    Michelotti G; Jiang X; Sosa JA; Diehl AM; Henderson BB
    Oncotarget; 2015 Oct; 6(33):34549-60. PubMed ID: 26416247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leucine-rich repeat-containing G protein-coupled receptor 5 and CD133 expression is associated with tumor progression and resistance to preoperative chemoradiotherapy in low rectal cancer.
    Harada Y; Kazama S; Morikawa T; Murono K; Yasuda K; Otani K; Nishikawa T; Tanaka T; Kiyomatsu T; Kawai K; Hata K; Nozawa H; Yamaguchi H; Ishihara S; Watanabe T
    Oncol Lett; 2017 Dec; 14(6):7791-7798. PubMed ID: 29250176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression Profile of LGR5 and Its Prognostic Significance in Colorectal Cancer Progression.
    Jang BG; Kim HS; Chang WY; Bae JM; Kim WH; Kang GH
    Am J Pathol; 2018 Oct; 188(10):2236-2250. PubMed ID: 30036518
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Implications and Prognostic Value of Leucine-Rich G Protein-Coupled Receptor 5 Expression as A Cancer Stem Cell Marker in Malignancies: A Systematic Review and Meta-Analysis.
    Ghobakhloo S; Khoshhali M; Vatandoost N; Jafarpour S; Niazmand A; Nedaeinia R; Salehi R
    Cell J; 2024 Jan; 26(1):1-12. PubMed ID: 38351725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of PD-L1 and PD-L2 Is Associated with Poor Prognosis in Patients with Hepatocellular Carcinoma.
    Jung HI; Jeong D; Ji S; Ahn TS; Bae SH; Chin S; Chung JC; Kim HC; Lee MS; Baek MJ
    Cancer Res Treat; 2017 Jan; 49(1):246-254. PubMed ID: 27456947
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-treatment serum levels of soluble programmed cell death-ligand 1 predict prognosis in patients with hepatitis B-related hepatocellular carcinoma.
    Han X; Gu YK; Li SL; Chen H; Chen MS; Cai QQ; Deng HX; Zuo MX; Huang JH
    J Cancer Res Clin Oncol; 2019 Feb; 145(2):303-312. PubMed ID: 30267213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneous expression of Lgr5 as a risk factor for focal invasion and distant metastasis of colorectal carcinoma.
    Zheng Z; Yu H; Huang Q; Wu H; Fu Y; Shi J; Wang T; Fan X
    Oncotarget; 2018 Jul; 9(53):30025-30033. PubMed ID: 30046385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LGR5, a relevant marker of cancer stem cells, indicates a poor prognosis in colorectal cancer patients: a meta-analysis.
    Han Y; Xue X; Jiang M; Guo X; Li P; Liu F; Yuan B; Shen Y; Guo X; Zhi Q; Zhao H
    Clin Res Hepatol Gastroenterol; 2015 Apr; 39(2):267-73. PubMed ID: 25193236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LGR5 promotes invasion and migration by regulating YAP activity in hypopharyngeal squamous cell carcinoma cells under inflammatory condition.
    Zhu Z; Yu S; Niu K; Wang P
    PLoS One; 2022; 17(10):e0275679. PubMed ID: 36288272
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of Musashi-1, Lgr5, and pEGFR expressions in human small intestinal adenocarcinomas.
    Wang Y; Jiang CQ; Fan LF
    Tumour Biol; 2015 Aug; 36(8):6075-82. PubMed ID: 25773390
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of cancer stem cell marker Lgr5 in colorectal cancer patients and association with clinicopathological findings.
    Shekarriz R; Montazer F; Alizadeh-Navaei R
    Caspian J Intern Med; 2019; 10(4):412-416. PubMed ID: 31814939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Up-Regulated Maternal Embryonic Leucine Zipper Kinase Predicts Poor Prognosis of Hepatocellular Carcinoma Patients in a Chinese Han Population.
    Wu S; Chen X; Hu C; Wang J; Shen Y; Zhong Z
    Med Sci Monit; 2017 Dec; 23():5705-5713. PubMed ID: 29192136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H
    J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of Nodal in hepatocellular carcinoma and its relationship with angiogenesis and epithelial-mesenchymal transition].
    Chen J; Li J; Liu W; Jia W; Xu G; Ma J
    Zhonghua Wai Ke Za Zhi; 2014 Mar; 52(3):188-92. PubMed ID: 24785457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LGR5 is a promising biomarker for patients with stage I and II gastric cancer.
    Bu Z; Zheng Z; Zhang L; Li Z; Sun Y; Dong B; Wu A; Wu X; Wang X; Cheng X; Xing X; Li Y; Du H; Ji J
    Chin J Cancer Res; 2013 Feb; 25(1):79-89. PubMed ID: 23372345
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.